The remote patient monitoring market size in the U.S was valued at USD 2523 Million in 2023. The U.S. market is estimated to grow at a CAGR of 16.14% from 2024 to 2032 and be worth USD 9699 million by 2032 from USD 2930 million in 2024.
The growing aging population in the U.S. and lifestyle changes are majorly driving the remote patient monitoring market in the U.S. The geriatric population is more prone to chronic illnesses like cardiovascular, diabetes, cancer, and others. According to a recent US Bureau data survey, the number of people aged above 65 is to reach more than 98 million, which is double the number of people in 2016 (46 million). It is significantly affecting the people who use these devices to have complete healthcare at home. It is predicted that there will be a lack of professionals in the coming years, and these new technologies will prompt healthcare services globally. Increasing healthcare costs and developing the latest techniques by researchers are propelling the growth rate of the market. The benefits conquered with the RPM devices, like fewer visits to hospitals and reduced time to stay in hospitals, enhance the market's growth rate. Remote patient monitoring devices are very useful in monitoring patients from different locations. These are gaining traction in giving excellent care for older people staying at home with chronic illnesses. These devices also provide the caregivers with proper assistance through the alert systems that are equipped in the device.
By 2030, the diabetes patient population may grow to 29.6% in the US. The number of heart-related disorders will triple in the coming years, according to the latest studies. Diabetes is the number one concern for all people worldwide, as the number of patients is surging every year. It is estimated that diabetes patients toll up to 25 million by 2030, particularly in the US. In 2011, the number of deaths due to diabetes was 4.6 million in this country.
Many private organizations have started using RPM techniques and are gaining traction through this. Traveling long distances is a big issue for geriatric people, who find it difficult to visit hospitals and clinics. RPM has sorted out this problem so far as it connects the healthcare professional and patient remotely. The attribute, as mentioned above, positively impacts the market growth in the U.S.
However, the lack of complete knowledge in operating the devices, especially in rural areas, is a big challenge that market players face. Failure of the systems in real-time applications also impedes the U.S. market growth. Risk factors included in RPM's use, such as the insertion of various devices like cardiac arrhythmias, air embolism, and others, are factors degrading the market's growth rate.
In the North American region, the U.S. is thriving to hit the largest share of the market. Growing incidences of chronic diseases like diabetes are leveling up the growth rate of the market. Besides, creating awareness through campaigns in rural areas and raising funds by government organizations accelerates market demand. People in urban areas are spending a large amount on healthcare, prompting the remote patient monitoring market in the United States.
Companies playing a promising role in the U.S. remote patient monitoring market profiled in this report are Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc, Honeywell, American Telecare, Biotronik, and Covidien Plc.
This research report on the U.S. remote patient monitoring market is segmented and sub-segmented into the following categories.
By Type
By Application
By End-Use
By Country
The United States
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region